|
|
|
|
Molecular Pharmacology, Vol 6, 604-616, Copyright © 1970 by the American Society for Pharmacology and Experimental Therapeutics
1 Department of Pharmacology and Experimental Therapeutics, School of Medicine, and
Department of Pathobiology, School of Hygiene and Public Health, The Johns
Hopkins University, Baltimore, Maryland 21205
The biochemical and chemotherapeutic effects of a number of nitroheterocyclic compounds, including niridazole [1-(5-nitro-2-thiazolyl)-2-imidazolidinone] and some 5-nitro-2-furyl derivatives, on Schistosoma mansoni were investigated. Those compounds which had marked schistosomicidal activity had common structural and conformational features. These comprised a 5-nitrothiazolyl or 5-nitrofuryl ring, with a nitrogen substituent (generally part of an amide or oxadiazole system) attached to C-2 via a rigid side chain. The latter contains either a C=C double bond or a nitrogen atom attached directly to C-2 of the heterocyclic ring. These features, which are illustrated in the accompanying structure, are believed to be
See PDF for Equation
essential for significant antischistosomal activity. The schistosomicidal effects of compounds of this structural type were invariably preceded by a reduction of phosphorylase phosphatase activity in the worms, suggesting a common mode of action.
Note:
ACKNOWLEDGMENTS
We are indebted to Dr. Arnold D. Welch of the
Squibb Institute for Medical Research and to Dr.
Herman Breuer of the Heyden Chemical Company
for the nitrofurans, to Dr. Ashton C. Cuckler and
Dr. William C. Campbell of Merck and Company
for aminitrozole, to Dr. Edward F. Elslager of
Parke, Davis and Company for the nitrosonaphthylamine, as well as to all of the above for the
mouse diets in which many of these compounds
had been incorporated, to Dr. Gerald Berkelhammer of American Cyanamid Company for the
pyridine- and quinoline-substituted nitrothiazoles,
and to Miss Geraldine Rose and Miss Mary Pyles
for valuable technical assistance.
This article has been cited by other articles:
![]() |
S. H. Rogers and E. Bueding Hycanthone Resistance: Development in Schistosoma mansoni Science, June 4, 1971; 172(3987): 1057 - 1058. [Abstract] [PDF] |
||||
![]() |
P. E. Hartman, K. Levine, Z. Hartman, and H. Berger Hycanthone: A Frameshift Mutagen Science, June 4, 1971; 172(3987): 1058 - 1060. [Abstract] [PDF] |
||||